Mindfulness meditation, a practice with deep roots in eastern traditions, has gained widespread public and scientific interest. Mindfulness is a natural state of present-moment awareness, and interventions have been developed to train this skill. This review discusses the concept of mindfulness and its use in treating psychiatric disorders. It identifies which patients benefit from mindfulness-based interventions and summarizes how they work, including cognitive, psychological, and neural mechanisms that drive clinical improvements. The review offers a foundation for incorporating these interventions into clinical practice.
Psychedelic-assisted psychotherapy is reemerging as a potential treatment for anxiety disorders, with accumulating evidence and likely FDA approval within 2-3 years. However, the field faces regulatory barriers, lack of clinician education, stigma, high costs, and a shortage of trained personnel. Ethical issues include responsibility toward indigenous peoples who historically used psychedelics and ongoing disparities in mental health access.
The use of psychedelics to treat depression is surrounded by both optimism and unresolved questions. The text examines the gap between high expectations and the current evidence base, highlighting that while early results are promising, significant uncertainties remain about efficacy, safety, and mechanisms of action. It calls for cautious interpretation and further rigorous research before these substances can be considered a standard treatment.